ATE146967T1 - Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern - Google Patents

Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern

Info

Publication number
ATE146967T1
ATE146967T1 AT92921364T AT92921364T ATE146967T1 AT E146967 T1 ATE146967 T1 AT E146967T1 AT 92921364 T AT92921364 T AT 92921364T AT 92921364 T AT92921364 T AT 92921364T AT E146967 T1 ATE146967 T1 AT E146967T1
Authority
AT
Austria
Prior art keywords
gamma
ifn
transplant recipients
treat infections
treatment
Prior art date
Application number
AT92921364T
Other languages
English (en)
Inventor
Christine Czarniecki
Jon B Klein
A David Slater
Gerald Sonnenfeld
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE146967T1 publication Critical patent/ATE146967T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92921364T 1991-10-07 1992-10-05 Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern ATE146967T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/773,382 US5248499A (en) 1991-10-07 1991-10-07 Control of microbial infections in transplant patients

Publications (1)

Publication Number Publication Date
ATE146967T1 true ATE146967T1 (de) 1997-01-15

Family

ID=25098084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921364T ATE146967T1 (de) 1991-10-07 1992-10-05 Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern

Country Status (20)

Country Link
US (1) US5248499A (de)
EP (1) EP0607258B1 (de)
JP (1) JP3467037B2 (de)
KR (1) KR100262063B1 (de)
AT (1) ATE146967T1 (de)
AU (1) AU666138B2 (de)
CA (1) CA2119236C (de)
DE (1) DE69216419T2 (de)
DK (1) DK0607258T3 (de)
ES (1) ES2097929T3 (de)
FI (1) FI941552L (de)
GR (1) GR3022672T3 (de)
HU (1) HU226455B1 (de)
IL (1) IL103341A (de)
NO (1) NO313576B1 (de)
NZ (1) NZ244615A (de)
PH (1) PH30211A (de)
PT (1) PT100932B (de)
WO (1) WO1993006847A1 (de)
ZA (1) ZA927677B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724838D0 (en) * 1997-11-26 1998-01-21 Franks Christopher R Compositions
CA2388005A1 (en) * 1999-09-28 2001-04-05 Joseph M. Cummins Low dose ifn-gamma for treatment of disease
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
WO2002022848A2 (en) * 2000-09-12 2002-03-21 Genetrol Biotherapeutics, Inc. Compositions comprising mixtures of human cytokines and methods of producing the same
AU2002246955B2 (en) * 2001-01-09 2007-03-22 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
EP2116228A1 (de) * 2001-10-19 2009-11-11 Isotechnika Inc. Neuartige Cyclosporinanalog-Mikroemulsionspräkonzentrate
WO2005065079A2 (en) * 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20070116678A1 (en) * 2005-11-23 2007-05-24 Hsing-Wen Sung Medical device with living cell sheet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2237767A (en) * 1989-11-09 1991-05-15 Cosgrove Tools Ltd Moulding machine ejector devices

Also Published As

Publication number Publication date
IL103341A0 (en) 1993-03-15
JPH07500106A (ja) 1995-01-05
PT100932A (pt) 1993-10-29
JP3467037B2 (ja) 2003-11-17
GR3022672T3 (en) 1997-05-31
NO941242L (no) 1994-06-03
HU9400984D0 (en) 1994-07-28
HU226455B1 (en) 2008-12-29
WO1993006847A1 (en) 1993-04-15
CA2119236C (en) 2007-05-22
NZ244615A (en) 1997-06-24
NO313576B1 (no) 2002-10-28
PH30211A (en) 1997-02-05
US5248499A (en) 1993-09-28
EP0607258B1 (de) 1997-01-02
KR940702735A (ko) 1994-09-17
DE69216419T2 (de) 1997-06-26
FI941552A0 (fi) 1994-04-05
PT100932B (pt) 1999-07-30
DK0607258T3 (da) 1997-04-14
CA2119236A1 (en) 1993-04-15
FI941552A7 (fi) 1994-04-05
NO941242D0 (no) 1994-04-06
ZA927677B (en) 1994-04-07
AU666138B2 (en) 1996-02-01
EP0607258A1 (de) 1994-07-27
ES2097929T3 (es) 1997-04-16
AU2762292A (en) 1993-05-03
HUT67008A (en) 1995-01-30
KR100262063B1 (ko) 2000-07-15
DE69216419D1 (de) 1997-02-13
IL103341A (en) 1997-11-20
FI941552L (fi) 1994-04-05

Similar Documents

Publication Publication Date Title
DE69532804D1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DK0675708T3 (da) Farmaceutiske og dermokosmetiske sammensætninger indeholdende heste-colostrum.
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69216419D1 (de) Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern
DK1675603T3 (da) Anvendelse af probiotiske bakterier i behandling af infektion
DE69008258D1 (de) S-adenosylmethionin zur behandlung von pankreatitis und der immunabstossung des pankreastransplantates.
FR2491334B1 (de)
DE59510667D1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DK0490384T3 (da) Fremgangsmåde til fremstilling af et pasteuriseret og jernfrit human-transferrin
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE165509T1 (de) Avermectine und milbemycine zur behandlung von parazitären infektionen beim hund
DK0391224T3 (da) Lægemiddel og anvendelse heraf til behandling af parasitoser
TR199800850T2 (xx) Kan� d�zenleyici bile�imler.
MY110041A (en) Composition and method of treating hepatitis c
ATE165508T1 (de) Verwendung von 2-methylamino-2-phenylcyclohexanon zur behandlung von infektionen und zur immunmodulation
ATE283063T1 (de) Allogene und xenogene transplantation
MXPA01010449A (es) Composicion y metodo util para el tratamiento del colico.
MX9400210A (es) Tratamiento de infecciones virales.
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
UA31289A (uk) Спосіб лікування запальних захворювань щелепо-лицевої ділянки

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification